StonvexLoading…
StonvexStonvexStonvexCore line items from MCD's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $6.52B | $26.89B | $19.88B | $12.80B |
Operating Income | $2.95B | $12.39B | $9.24B | $5.88B |
Net Income | $1.98B | $8.56B | $6.40B | $4.12B |
EPS (Diluted) | $2.78 | $11.95 | $8.92 | $5.74 |
Total Assets | $60.04B | $59.52B | $60.61B | $59.55B |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $1.17B | $774.00M | $2.41B | $1.88B |
Free Cash Flow OCF − CapEx | $1.73B | $7.19B | $5.55B | $3.13B |
Shares Outstanding | 713.5 | 716.4 | 717.2 | 717.9 |